The Life Sciences industry is constantly in flux, driven by advancements in therapeutic innovation, changing regulatory standards, and a rapid shift from traditional treatments to complex, novel therapies. In this dynamic and competitive landscape, Contract Development and Manufacturing Organizations (CDMOs) have become strategic partners in transforming early-stage scientific breakthroughs into safe, effective, patient-ready products. They...